These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 5529430)
1. [Problems in the administration of antibiotics to the patients with myasthenia gravis]. Onishi A; Shida K; Kuroiwa Y Naika; 1970 Nov; 26(5):926-9. PubMed ID: 5529430 [No Abstract] [Full Text] [Related]
2. [Exacerbation of pseudoparalytic myasthenia gravis following azithromycin (Zithromax)]. Cadisch R; Streit E; Hartmann K Schweiz Med Wochenschr; 1996 Feb; 126(8):308-10. PubMed ID: 8701248 [TBL] [Abstract][Full Text] [Related]
3. [Problems of antibiotic administration in myasthenia gravis]. Onishi A; Shida K; Kuroiwa Y Shinkei Kenkyu No Shimpo; 1971; 15(4):906-10. PubMed ID: 4334475 [No Abstract] [Full Text] [Related]
4. [Antibiotics and myasthenia gravis]. Igata A Shinkei Kenkyu No Shimpo; 1971; 15(4):910-3. PubMed ID: 5168643 [No Abstract] [Full Text] [Related]
5. Prulifloxacin as a trigger of myasthenia gravis. Rossi M; Lusini G; Biasella A; Mazzocchio R J Neurol Sci; 2009 May; 280(1-2):109-10. PubMed ID: 19232642 [TBL] [Abstract][Full Text] [Related]
6. Myasthenia gravis accompanied with hypokalemic periodic paralysis. Sawanyawisuth K; Tiamkao S; Pratipanawatr T J Med Assoc Thai; 2006 May; 89(5):727-9. PubMed ID: 16756062 [TBL] [Abstract][Full Text] [Related]
7. Drugs that may exacerbate myasthenia gravis. Adams SL; Mathews J; Grammer LC Ann Emerg Med; 1984 Jul; 13(7):532-8. PubMed ID: 6742556 [TBL] [Abstract][Full Text] [Related]
11. [Drugs and myasthenia gravis]. Jusić A Lijec Vjesn; 1984 Jan; 106(1):42-3. PubMed ID: 6708718 [No Abstract] [Full Text] [Related]
12. [Problems in the therapy of myasthenia gravis associated with hyperthyroidism]. Ledić P; Milohanović S; Jurjević A Srp Arh Celok Lek; 1982 Jun; 110(6):771-4. PubMed ID: 7170660 [No Abstract] [Full Text] [Related]
13. Antibiotics in myasthenia gravis: Thinking outside the black box. Cea G; Salinas RA Muscle Nerve; 2021 Aug; 64(2):123-124. PubMed ID: 34089196 [No Abstract] [Full Text] [Related]
14. The effect of use of pyridostigmine and requirement of vecuronium in patients with myasthenia gravis. Tripathi M; Kaushik S; Dubey P J Postgrad Med; 2003; 49(4):311-4; discussion 314-5. PubMed ID: 14699228 [TBL] [Abstract][Full Text] [Related]
15. Benefits of FK506 (tacrolimus) for residual, cyclosporin- and prednisone-resistant myasthenia gravis: one-year follow-up of an open-label study. Ponseti JM; Azem J; Fort JM; Codina A; Montoro JB; Armengol M Clin Neurol Neurosurg; 2005 Apr; 107(3):187-90. PubMed ID: 15823673 [TBL] [Abstract][Full Text] [Related]
17. Education and imaging. Gastrointestinal: Mycobacterium genavense enteritis in an immunosuppressed patient. Sharifian A; Humphris J; Leong RW; Jones DB J Gastroenterol Hepatol; 2009 Aug; 24(8):1474. PubMed ID: 19702915 [No Abstract] [Full Text] [Related]
18. Telithromycin: visual disorders, myasthenia. Case fatalities: this macrolide has a negative risk-benefit balance; its use not justified. Prescrire Int; 2008 Apr; 17(94):66. PubMed ID: 18516818 [No Abstract] [Full Text] [Related]
19. [Further observations on side effects of intravenous administration of reverin in myasthenia gravis pseudoparalytica]. Gibbels E Dtsch Med Wochenschr; 1967 Jun; 92(25):1153-4. PubMed ID: 6026478 [No Abstract] [Full Text] [Related]